A $55,000 drug that doesn’t cure Alzheimer’s
Today, Explained
Intro
This chapter explores the groundbreaking FDA approval of a new drug for Alzheimer's disease, highlighting its importance as a hopeful breakthrough in treatment options. It emphasizes the renewed optimism for patients and advancements in medical science aimed at combating this challenging condition.
00:00
Transcript
Play full episode
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
